Hsbc Holdings PLC Regeneron Pharmaceuticals, Inc. Transaction History

Hsbc Holdings PLC

  • $168 Billion
  • Q4 2024

A detailed history of Hsbc Holdings PLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 433,804 shares of REGN stock, worth $305 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
433,804
Previous 357,084 21.49%
Holding current value
$305 Million
Previous $375 Million 17.68%
% of portfolio
0.18%
Previous 0.22%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$701.85 - $1046.91 $53.8 Million - $80.3 Million
76,720 Added 21.49%
433,804 $309 Million
Q3 2024

Nov 14, 2024
SELL
$1024.09 - $1201.76 $9.05 Million - $10.6 Million
-8,841 Reduced 2.42%
357,084 $375 Million
Q2 2024

Aug 12, 2024
SELL
$883.2 - $1071.19 $10.2 Million - $12.3 Million
-11,501 Reduced 3.05%
365,925 $385 Million
Q1 2024

May 15, 2024
BUY
$902.69 - $993.35 $47.3 Million - $52.1 Million
52,414 Added 16.13%
377,426 $363 Million
Q4 2023

Feb 12, 2024
BUY
$775.18 - $881.7 $43.4 Million - $49.4 Million
56,010 Added 20.82%
325,012 $285 Million
Q3 2023

Nov 13, 2023
SELL
$692.45 - $844.37 $23.3 Million - $28.4 Million
-33,661 Reduced 11.12%
269,002 $221 Million
Q2 2023

Aug 11, 2023
BUY
$700.03 - $830.35 $32.8 Million - $38.9 Million
46,863 Added 18.32%
302,663 $217 Million
Q1 2023

May 15, 2023
SELL
$680.49 - $826.97 $1.23 Million - $1.49 Million
-1,805 Reduced 0.7%
255,800 $210 Million
Q4 2022

Feb 14, 2023
BUY
$705.89 - $766.39 $50.7 Million - $55.1 Million
71,846 Added 38.68%
257,605 $186 Million
Q3 2022

Nov 14, 2022
BUY
$573.97 - $724.32 $16.3 Million - $20.6 Million
28,396 Added 18.04%
185,759 $128 Million
Q2 2022

Aug 11, 2022
BUY
$548.35 - $738.84 $36.3 Million - $48.9 Million
66,224 Added 72.66%
157,363 $93.5 Million
Q1 2022

May 16, 2022
SELL
$595.12 - $698.43 $3.45 Million - $4.04 Million
-5,791 Reduced 5.97%
91,139 $63.5 Million
Q4 2021

Feb 11, 2022
SELL
$543.48 - $670.97 $12.4 Million - $15.3 Million
-22,829 Reduced 19.06%
96,930 $61.2 Million
Q3 2021

Nov 12, 2021
SELL
$574.03 - $680.96 $6.84 Million - $8.12 Million
-11,919 Reduced 9.05%
119,759 $72.6 Million
Q2 2021

Aug 13, 2021
SELL
$472.8 - $558.54 $63.7 Million - $75.3 Million
-134,728 Reduced 50.57%
131,678 $73.5 Million
Q1 2021

May 14, 2021
BUY
$446.73 - $548.2 $62.3 Million - $76.4 Million
139,352 Added 109.68%
266,406 $126 Million
Q4 2020

Feb 25, 2021
SELL
$478.3 - $607.98 $26 Million - $33 Million
-54,300 Reduced 29.94%
127,054 $61.4 Million
Q4 2020

Feb 12, 2021
BUY
$478.3 - $607.98 $49.1 Million - $62.5 Million
102,743 Added 130.7%
181,354 $87.6 Million
Q3 2020

Nov 12, 2020
BUY
$544.75 - $658.21 $1.77 Million - $2.14 Million
3,255 Added 4.32%
78,611 $44.7 Million
Q2 2020

Aug 14, 2020
BUY
$493.32 - $643.92 $2.3 Million - $3 Million
4,657 Added 6.59%
75,356 $47 Million
Q1 2020

May 15, 2020
SELL
$336.18 - $494.43 $6.23 Million - $9.17 Million
-18,539 Reduced 20.77%
70,699 $34.1 Million
Q4 2019

Feb 14, 2020
SELL
$274.13 - $376.51 $1.73 Million - $2.37 Million
-6,303 Reduced 6.6%
89,238 $33.4 Million
Q3 2019

Nov 14, 2019
BUY
$273.46 - $318.39 $2.82 Million - $3.28 Million
10,310 Added 12.1%
95,541 $26.5 Million
Q2 2019

Aug 13, 2019
BUY
$299.6 - $414.82 $8.11 Million - $11.2 Million
27,064 Added 46.53%
85,231 $26.7 Million
Q1 2019

May 15, 2019
BUY
$372.08 - $439.57 $2.19 Million - $2.59 Million
5,895 Added 11.28%
58,167 $23.9 Million
Q4 2018

Feb 13, 2019
SELL
$335.82 - $403.04 $2.41 Million - $2.9 Million
-7,190 Reduced 12.09%
52,272 $19.5 Million
Q3 2018

Nov 13, 2018
BUY
$351.14 - $408.51 $4.89 Million - $5.68 Million
13,914 Added 30.55%
59,462 $24 Million
Q2 2018

Aug 10, 2018
SELL
$284.6 - $344.99 $7.65 Million - $9.28 Million
-26,891 Reduced 37.12%
45,548 $15.7 Million
Q1 2018

May 11, 2018
SELL
$315.82 - $393.78 $25.3 Million - $31.5 Million
-79,994 Reduced 52.48%
72,439 $24.9 Million
Q4 2017

Feb 14, 2018
BUY
$358.63 - $469.95 $38.7 Million - $50.7 Million
107,783 Added 241.4%
152,433 $57.3 Million
Q3 2017

Nov 14, 2017
SELL
$431.38 - $504.0 $7.76 Million - $9.07 Million
-17,998 Reduced 28.73%
44,650 $20 Million
Q2 2017

Aug 14, 2017
BUY
N/A
62,648
62,648 $30.8 Million

Others Institutions Holding REGN

# of Institutions
1,490
Shares Held
85.7M
Call Options Held
1.53M
Put Options Held
1.44M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email